Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Otolaryngology
Volume 2018 (2018), Article ID 5965029, 4 pages
https://doi.org/10.1155/2018/5965029
Case Report

A Very Rare Case of Hypereosinophilic Syndrome Secondary to Natural Killer/T-Cell Lymphoma

1Department of Otorhinolaryngology and Head & Neck Surgery, University of Yamanashi, Yamanashi, Japan
2Department of Otorhinolaryngology and Allergy Center, Saitama Medical University, Saitama, Japan
3Department of Pathology, University of Yamanashi, Yamanashi, Japan
4Department of Hematology and Oncology, University of Yamanashi, Yamanashi, Japan
5Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan

Correspondence should be addressed to Takanori Yamamoto; pj.oc.oohay@kcitstaeb

Received 28 August 2017; Revised 6 February 2018; Accepted 18 February 2018; Published 26 March 2018

Academic Editor: Rong-San Jiang

Copyright © 2018 Takanori Yamamoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Valent, A. D. Klion, H. P. Horny et al., “Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndrome,” Journal of Allergy and Clinical Immunology, vol. 130, no. 3, pp. 607–612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Arber, A. Orazi, R. Hasseriian et al., “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia,” Blood, vol. 127, no. 20, pp. 2391–2405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Cools, D. J. Deangelo, J. Gotlib et al., “A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome,” New England Journal of Medicine, vol. 348, no. 13, pp. 1201–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. MS. Muller, U. M. Martens, S. C. Hofmann, L. Bruckner-Tuderman, R. Mertelsmann, and M. Lübbert, “Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature,” Annals of Hematology, vol. 85, no. 1, pp. 1–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sada, Y. Katayama, K. Yamamoto et al., “A multicenter analysis of the FIP1L1-αPDGFR fusion gene in Japanese idiopathic hypereosinophilic syndrome: an aberrant splicing skipping the αPDGFR exon 12,” Annals of Hematology, vol. 86, no. 12, pp. 855–863, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D’Souza, A. Pardanani, and A. Tefferi, “Lymphoma-associated versus lymphocytic-variant hypereosinophilia,” Leukemia and Lymphoma, vol. 53, no. 11, pp. 2103-2104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. R. Fernández, J. R. P. Pardo, A. Doyle, M. C. Albendea, and A. R. de la Rúa, “Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: a case report and literature review,” Leukemia Research, vol. 35, no. 7, pp. e97–e99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. D. Klion, R. Mejia, E. W. Cowen et al., “Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome,” Blood, vol. 121, no. 12, pp. 2364–2366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Wang, Z. Wang, Z. Xia, Y. Lu, H. Huang, and Y. Zhang, “CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis,” Tumor Biology, vol. 36, no. 10, pp. 7717–7723, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. X. Li, H. Wang, X. L. Feng et al., “Immunophenotypic characteristics and clinical relevance of CD56+ and CD56− extranodal nasal-type natural killer/T-cell lymphoma,” Leukemia and Lymphoma, vol. 52, no. 3, pp. 417–424, 2011. View at Publisher · View at Google Scholar · View at Scopus